Quanterix Corp (QTRX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $139.11M
Last updated: Nov 17, 2026 at 11:06 AM ET
Quanterix Corp (QTRX) Earnings: Report Dates and Results
Quanterix (QTRX) is expected to report earnings on Jan 6, 2027. In the quarter ended Sep 30, 2026, Quanterix reported EPS of -$0.46, above the -$0.49 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
QTRX has an expected report date of Jan 6, 2027.
QTRX Earnings Call
The latest QTRX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 36 quarters below that had an estimate, QTRX beat 20 and missed 16. Revenue for the quarter ended Sep 30, 2026 was $34.97M, down 13.1% from $40.23M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.46 | -$0.49 | N/A | +6.12% | Beat | N/A | 3 | 1 up, 0 down | Nov 9, 2026 | $34.97M |
| Jun 30, 2026 | -$0.45 | -$0.56 | N/A | +19.64% | Beat | N/A | 3 | 0 up, 1 down | Aug 10, 2026 | $32.91M |
| Mar 31, 2026 | $0.16 | -$0.62 | -$0.62 - -$0.62 | +125.81% | Beat | N/A | 1 | 0 up, 0 down | May 6, 2026 | $36.41M |
| Dec 31, 2025 | -$0.47 | -$0.43 | -$0.67 - -$0.27 | -8.75% | Miss | N/A | 3 | 1 up, 2 down | Mar 2, 2026 | $43.85M |
| Sep 30, 2025 | -$0.73 | -$0.53 | -$0.71 - -$0.23 | -37.74% | Miss | N/A | 3 | 1 up, 0 down | Nov 10, 2025 | $40.23M |
| Jun 30, 2025 | -$0.47 | -$0.41 | N/A | -14.63% | Miss | N/A | N/A | 0 up, 0 down | Aug 7, 2025 | $24.48M |
| Mar 31, 2025 | -$0.53 | -$0.43 | N/A | -23.26% | Miss | N/A | N/A | 0 up, 0 down | May 12, 2025 | $30.33M |
| Dec 31, 2024 | -$0.30 | -$0.25 | -$0.26 - -$0.19 | -18.11% | Miss | N/A | 6 | 0 up, 0 down | Mar 17, 2025 | $35.16M |
| Sep 30, 2024 | -$0.22 | -$0.23 | -$0.30 - -$0.20 | +4.35% | Beat | N/A | 6 | 0 up, 0 down | Nov 11, 2024 | $35.81M |
| Jun 30, 2024 | -$0.25 | -$0.26 | -$0.30 - -$0.21 | +3.85% | Beat | N/A | 6 | 0 up, 0 down | Aug 8, 2024 | $34.38M |
| Mar 31, 2024 | -$0.26 | -$0.31 | -$0.36 - -$0.27 | +16.13% | Beat | N/A | 4 | 0 up, 0 down | May 7, 2024 | $32.07M |
| Dec 31, 2023 | -$0.33 | -$0.32 | -$0.38 - -$0.28 | -3.13% | Miss | N/A | 5 | 0 up, 0 down | Feb 29, 2024 | $31.55M |
| Sep 30, 2023 | -$0.21 | -$0.40 | -$0.40 - -$0.35 | +47.50% | Beat | N/A | 4 | 1 up, 1 down | Nov 6, 2023 | $31.56M |
| Jun 30, 2023 | -$0.13 | -$0.41 | -$0.41 - -$0.35 | +68.29% | Beat | N/A | 4 | 1 up, 0 down | Aug 7, 2023 | $30.80M |
| Mar 31, 2023 | -$0.14 | -$0.38 | -$0.40 - -$0.36 | +63.16% | Beat | N/A | 4 | 0 up, 0 down | May 9, 2023 | $28.46M |
| Dec 31, 2022 | -$0.50 | -$0.47 | -$0.53 - -$0.38 | -6.38% | Miss | N/A | 4 | 0 up, 0 down | Mar 6, 2023 | $25.82M |
| Sep 30, 2022 | -$0.40 | -$0.44 | -$0.58 - -$0.24 | +9.09% | Beat | N/A | 4 | 1 up, 0 down | Nov 8, 2022 | $26.65M |
| Jun 30, 2022 | -$0.67 | -$0.59 | -$0.67 - -$0.25 | -13.56% | Miss | N/A | 4 | 0 up, 1 down | Aug 8, 2022 | $23.50M |
| Mar 31, 2022 | -$0.49 | -$0.61 | -$0.67 - -$0.47 | +19.67% | Beat | N/A | 4 | 0 up, 0 down | May 10, 2022 | $29.55M |
| Dec 31, 2021 | -$0.55 | -$0.66 | -$0.73 - -$0.55 | +16.67% | Beat | N/A | 6 | N/A | Mar 1, 2022 | $30.29M |
| Sep 30, 2021 | -$0.43 | -$0.33 | -$0.42 - -$0.24 | -30.30% | Miss | N/A | 6 | 2 up, 0 down | Nov 4, 2021 | $27.69M |
| Jun 30, 2021 | -$0.31 | -$0.33 | -$0.37 - -$0.24 | +6.06% | Beat | N/A | 5 | N/A | Aug 5, 2021 | $25.37M |
| Mar 31, 2021 | -$0.29 | -$0.34 | -$0.44 - -$0.28 | +14.71% | Beat | N/A | 5 | N/A | May 5, 2021 | $27.21M |
| Dec 31, 2020 | -$0.31 | -$0.33 | -$0.43 - -$0.19 | +6.06% | Beat | N/A | 5 | N/A | Mar 2, 2021 | $26.13M |
| Sep 30, 2020 | -$0.26 | -$0.42 | -$0.46 - -$0.39 | +38.10% | Beat | N/A | 5 | N/A | Nov 5, 2020 | $31.39M |
| Jun 30, 2020 | -$0.41 | -$0.50 | -$0.53 - -$0.41 | +18.00% | Beat | N/A | 4 | N/A | Aug 4, 2020 | $13.13M |
| Mar 31, 2020 | -$0.38 | -$0.41 | -$0.48 - -$0.31 | +7.32% | Beat | N/A | 5 | N/A | May 5, 2020 | $15.73M |
| Dec 31, 2019 | -$0.39 | -$0.43 | -$0.55 - -$0.36 | +9.30% | Beat | N/A | 5 | N/A | Mar 13, 2020 | $15.92M |
| Sep 30, 2019 | -$0.34 | -$0.44 | -$0.54 - -$0.36 | +22.73% | Beat | N/A | 5 | N/A | Nov 8, 2019 | $14.94M |
| Jun 30, 2019 | -$0.46 | -$0.42 | -$0.48 - -$0.35 | -9.52% | Miss | N/A | 5 | N/A | Aug 6, 2019 | $13.54M |
| Mar 31, 2019 | -$0.42 | -$0.40 | -$0.47 - -$0.34 | -5.00% | Miss | N/A | 5 | N/A | May 10, 2019 | $12.34M |
| Dec 31, 2018 | -$0.39 | -$0.31 | -$0.38 - -$0.23 | -25.81% | Miss | N/A | 5 | N/A | Mar 18, 2019 | $10.88M |
| Sep 30, 2018 | -$0.35 | -$0.31 | N/A | -12.90% | Miss | N/A | N/A | N/A | Nov 7, 2018 | $10.59M |
| Jun 30, 2018 | -$0.34 | -$0.29 | N/A | -17.24% | Miss | N/A | N/A | N/A | Aug 10, 2018 | $8.64M |
| Mar 31, 2018 | -$0.33 | -$0.27 | N/A | -22.22% | Miss | N/A | N/A | N/A | May 15, 2018 | $7.52M |
| Dec 31, 2017 | -$1.06 | -$0.32 | N/A | -231.25% | Miss | N/A | N/A | N/A | Mar 19, 2018 | $6.59M |
| Sep 30, 2017 | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 15, 2017 | $5.73M |
| Jun 30, 2017 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 21, 2017 | $5.21M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.20, after -$1.03 the year before. It was -$2.18 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.20 | N/A |
| Dec 31, 2024 | -$1.03 | N/A |
| Dec 31, 2023 | -$0.81 | N/A |
| Dec 31, 2022 | -$2.06 | N/A |
| Dec 31, 2021 | -$1.58 | N/A |
| Dec 31, 2020 | -$1.36 | N/A |
| Dec 31, 2019 | -$1.61 | N/A |
| Dec 31, 2018 | -$1.41 | N/A |
| Dec 31, 2017 | -$2.18 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,800 words across 8 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,802 | 8 | |
| 2026Q2 | Jun 30, 2026 | 7,483 | 8 | |
| 2026Q1 | Mar 31, 2026 | 4,456 | 7 | |
| 2025Q4 | Dec 31, 2025 | 3,569 | 7 | |
| 2025Q3 | Sep 30, 2025 | 5,083 | 8 | |
| 2025Q2 | Jun 30, 2025 | 2,715 | 6 | |
| 2025Q1 | Mar 31, 2025 | 6,655 | 9 | |
| 2024Q4 | Dec 31, 2024 | 5,450 | 9 |
2026Q3 Earnings Call
Opening remarks
Mary Conway Investor Relations Thank you, and good morning. With me on today's call are Everett Cunningham, Quanterix's President and CEO, and Jason Faessler, Quanterix's Chief Financial Officer. Today's call is being recorded, and a replay of the call will be available on the Investors section of our website. During today's presentation, we will make forward-looking statements covered under the U.S. Private Securities Litigation Reform Act. These forward-looking statements are based on management's beliefs and assumptions as of today, November 9, 2026. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. To supplement our financial statements presented on a GAAP basis, we have provided certain non-GAAP financial measures. These non-GAAP measures are used to evaluate our operating performance in a manner that allows for meaningful period-to-period comparison and analysis of trends in our business and our competitors. We believe that such measures are important in comparing current results with other periods' results and assessing our operating performance within our industry. Non-GAAP financial information presented herein should be considered in conjunction with, and not as a substitute for, the financial information presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures set forth in the presentation posted to our website and in the earnings release issued today. Finally, any percentage changes we discuss will be on a year-over-year basis unless otherwise noted. Now I'd like to turn the call over to Everett Cunningham. Everett?
Everett Cunningham President and CEO Thanks, Mary, and good morning, everybody. I'm happy to share that we exceeded our expectations for top-line performance in the third quarter, with sequential revenue growth of 6.3% and an improvement across the business. These results reflect the hard work of our entire team. Our solid Q3 results are an important early proof point in our path to restoring growth, and there's more. As shown on Slide 3, our commercial teams performed better across the board despite continued market softness, with strong sequential growth across all product categories and technology platforms. The Americas region posted the strongest improvement, with high-teens percentage growth. Spatial consumables were at a near-record level, demonstrating that our instrument installed base is being utilized. We're pleased with these first elements of recovery at Quanterix, which are reversing the revenue decline trend from last year.
Frequently Asked Questions About QTRX
When is Quanterix's next earnings date?
Quanterix's next earnings report is expected for Jan 6, 2027.
Did QTRX beat earnings estimates last quarter?
Yes. Quanterix reported EPS of -$0.46 for the quarter ended Sep 30, 2026, above the -$0.49 estimate, a 6.12% surprise.
What EPS do analysts expect from QTRX next quarter?
The consensus EPS estimate for Quanterix for the quarter ending Dec 31, 2026 is -$0.41 from 5 analysts, with estimates from -$0.44 to -$0.37.
How often does QTRX beat earnings estimates?
Quanterix beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +6.14%.
QTRX pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts